Intuitive Doesn't Give Away the Razor. It Sells the Blade a Chip Won't Let You Refuse.

Somewhere inside the wrist of a da Vinci surgical instrument is a small chip that does only one job: it counts. Every time a surgeon uses the instrument, the counter ticks down. At twelve or fourteen uses, depending on the program, the instrument simply stops working - not because the steel is worn out, but because the chip says it is done.⁷ The hospital paid a million dollars or more for the robot. Now it has to keep buying the blades, and the robot itself decides when. In 2024, that quiet little counter helped move roughly 2,683,000 procedures through the system and generated more than $8.35 billion in revenue.² The genius isn't a cheap razor. It's that the blade tells you when to buy the next one.

The official story is that Intuitive runs a razor-and-blades model: give away the da Vinci, lose money on the hardware, and print profits on disposable instruments forever after. Almost none of that is true. Intuitive sells the razor at a healthy profit, the instruments aren't disposable, and the company doesn't even use the razor-and-blades label in its own filings. The lock-in is real and it is brutal - but it isn't built on a subsidized robot. It's built on a chip, a training program, and 9,902 systems that nobody can afford to walk away from.

The razor isn't a loss-leader. It's a profit center wearing a disguise.

Start with the number that demolishes the myth. Intuitive's FY2024 10-K reports roughly 67% total gross margin across every revenue line - systems included.¹ A loss-leader is, by definition, sold below cost. The da Vinci is sold for between $0.7 million and $3.1 million depending on model and geography, and it makes money doing so.¹ The newest da Vinci 5 carries a gross average selling price about 30% above the older Xi, and lands somewhere between $1.8 million and $2.5 million.³⁴ You do not raise the price 30% on a product you're using to lose money. You raise it because the hardware itself is profitable and you intend to keep it that way.

So the standard analogy gets the mechanism exactly backwards. The instruments don't carry the system; the system carries itself, and the instruments carry the compounding. In FY2024, systems were only about 23.5% of revenue - $1,966 million of $8,352 million.¹ The other three-quarters came from instruments, accessories, and service: recurring revenue, around 76.5%, that grows every time someone, somewhere, performs another operation.¹ That's not razor-and-blades. It's a profitable razor that also happens to ring a bell every time the blade is used - and the bell never stops.

The chip is the lock, and the surgeon is the key that can't leave

If the hardware is profitable and the instruments aren't given away, where is the moat? It's in the cost of leaving. Three things weld a hospital to da Vinci, and none of them is price. The first is the embedded chip - EndoWrist technology - which caps each instrument's life and forces a fresh purchase, at $800 to $3,600 in instruments and accessories per procedure.¹⁷ You cannot route around it with a generic blade, because the robot won't accept one. The second is the service contract, $100,000 to $225,000 a year, that keeps the system running and the relationship intimate.¹ The third, and the heaviest, is the surgeon.

A surgeon trained on da Vinci has spent years building muscle memory inside Intuitive's specific console, instrument set, and motion grammar. Switching robots doesn't mean swapping a vendor; it means retraining the most expensive, time-scarce people in the building, on a live business of cutting into human bodies. No hospital administrator volunteers for that. So the installed base isn't just 9,902 machines - it's 9,902 machines surrounded by trained surgeons, signed service contracts, and a procedure habit that deepens with every case.² The robot is the anchor. The surgeon is the chain. And the chip makes sure the meter never stops running.

Isn't this just rent on a chip - and can't a rival undercut it?

The fair objection is that the EndoWrist chip looks like artificial scarcity: instruments that could be reused more, capped by software so the hospital has to keep paying. There's truth in it - Intuitive's own 2020 Extended Use Program quietly raised the cap from 10 uses to 12-14, which is an admission that the limit was always a business decision as much as an engineering one.⁷ But the chip alone isn't the moat. A chip is copyable. What isn't copyable is the surrounding system: the clinical evidence built over millions of procedures, the surgeon training entrenched across nearly 10,000 sites, and the regulatory trust that a hospital is literally betting patient outcomes on. A rival could sell a cheaper robot tomorrow - several do, for hundreds of thousands of dollars to over $1 million.⁴ The hard part isn't building a robot. It's convincing a hospital to retrain its surgeons and re-prove its safety record to save on instruments. That's the switching cost, and it's denominated in years and lives, not dollars.

The honest counter is that the position is being tested. Tariffs are nibbling at margin - roughly a 1% headwind baked into FY2026 guidance.⁶ Cheaper competitors keep arriving, and every hospital cost committee in the world is staring at per-case economics in that range — one physician analyst's review of Intuitive's 2024 data put it at roughly $3,300 per case — and asking whether there's a way out.⁴ But the math that protects Intuitive is the same math that built it: procedures only grow. Full-year 2025 saw roughly 3,153,000 procedures, up from 2.68 million the year before, and Q1 2026 revenue hit $2.77 billion, up 23%.⁵⁶ The faster the world adopts robotic surgery, the deeper the existing base entrenches - because every new case is performed on the robot the surgeon already knows, accepting the blade the chip already counts.

Intuitive makes its money the way a tollkeeper does on a road only it knows how to build - except the toll isn't on the road, it's on every wrist that moves across it. The da Vinci was never the loss-leader the story claims; it was profitable from the first sale. The real trick was quieter and more permanent: train the surgeons, sign the service contracts, and put a counter inside the blade so the customer never has to be reminded to come back. The chip does the reminding. And as the world keeps moving more surgery onto robots, a little more of it moves onto Intuitive's - where the razor was never cheap, the blade was never free, and the only thing given away was the illusion that anyone could ever switch.